Matches in SemOpenAlex for { <https://semopenalex.org/work/W4312210712> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- W4312210712 endingPage "328" @default.
- W4312210712 startingPage "322" @default.
- W4312210712 abstract "Hydrazine is an alkaline reduction compound which is widely used in synthesis. Based on the structure-activity analysis, to elicit antitumor activity, the presence of the N-methyl group is an absolute requirement. The aim of the research is to synthesize a new hydrazine derivate compound that has potency as a novel anti-breast cancer. 4-hydrazinylphenyl benzenesulfonate was synthesized employing reduction and diazotization methods. Structure characterization was carried out using Fourier transform infrared (FTIR), C13-nuclear magnetic resonance (NMR), H1-NMR, and High Resolution Time-of-Flight Mass Spectrometry (HR-TOF-MS). The anti-cancer activity of this compound against breast cancer Michigan Cancer Foundation-7 (MCF-7) cell line was determined using a PrestoBlue viability assay. The new of hydrazine derivative, 4-hydrazinylphenyl benzenesulfonate, has been successfully synthesized. The reduction and diazotization methods have been successfully used in the synthesis of new compound of hydrazine derivatives. Structure characterization of 4-hydrazinylphenyl benzenesulfonate was established using FTIR, C13-NMR, H1-NMR, and HR-TOF-MS. The anti-cancer activity of this compound against breast cancer MCF-7 cell line was determined using a PrestoBlue viability assay with IC50 0.00246 μg/mL or 9.32 nM. In conclusion, 4-hydrazinylphenyl benzenesulfonate was successfully synthesized as a new candidate for anti-breast cancer compound." @default.
- W4312210712 created "2023-01-04" @default.
- W4312210712 creator A5015137815 @default.
- W4312210712 creator A5047031793 @default.
- W4312210712 creator A5073839317 @default.
- W4312210712 creator A5087710330 @default.
- W4312210712 date "2022-12-27" @default.
- W4312210712 modified "2023-10-03" @default.
- W4312210712 title "Nanomolar activity of 4-hydrazinylphenyl benzenesulfonate against breast cancer Michigan Cancer Foundation-7 cell lines." @default.
- W4312210712 cites W1992939091 @default.
- W4312210712 cites W1995268204 @default.
- W4312210712 cites W1998440426 @default.
- W4312210712 cites W2015885169 @default.
- W4312210712 cites W2069874395 @default.
- W4312210712 cites W2092678986 @default.
- W4312210712 cites W2101470653 @default.
- W4312210712 cites W2107639011 @default.
- W4312210712 cites W2115187133 @default.
- W4312210712 cites W2127413706 @default.
- W4312210712 cites W2129046210 @default.
- W4312210712 cites W2340273608 @default.
- W4312210712 cites W2518046346 @default.
- W4312210712 cites W2885889543 @default.
- W4312210712 cites W2899070097 @default.
- W4312210712 cites W2911188335 @default.
- W4312210712 doi "https://doi.org/10.4103/japtr.japtr_435_22" @default.
- W4312210712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36568052" @default.
- W4312210712 hasPublicationYear "2022" @default.
- W4312210712 type Work @default.
- W4312210712 citedByCount "1" @default.
- W4312210712 countsByYear W43122107122023 @default.
- W4312210712 crossrefType "journal-article" @default.
- W4312210712 hasAuthorship W4312210712A5015137815 @default.
- W4312210712 hasAuthorship W4312210712A5047031793 @default.
- W4312210712 hasAuthorship W4312210712A5073839317 @default.
- W4312210712 hasAuthorship W4312210712A5087710330 @default.
- W4312210712 hasConcept C103319777 @default.
- W4312210712 hasConcept C121608353 @default.
- W4312210712 hasConcept C126322002 @default.
- W4312210712 hasConcept C127413603 @default.
- W4312210712 hasConcept C13965031 @default.
- W4312210712 hasConcept C160892712 @default.
- W4312210712 hasConcept C185592680 @default.
- W4312210712 hasConcept C21951064 @default.
- W4312210712 hasConcept C2776597398 @default.
- W4312210712 hasConcept C42360764 @default.
- W4312210712 hasConcept C43617362 @default.
- W4312210712 hasConcept C530470458 @default.
- W4312210712 hasConcept C71240020 @default.
- W4312210712 hasConcept C71924100 @default.
- W4312210712 hasConceptScore W4312210712C103319777 @default.
- W4312210712 hasConceptScore W4312210712C121608353 @default.
- W4312210712 hasConceptScore W4312210712C126322002 @default.
- W4312210712 hasConceptScore W4312210712C127413603 @default.
- W4312210712 hasConceptScore W4312210712C13965031 @default.
- W4312210712 hasConceptScore W4312210712C160892712 @default.
- W4312210712 hasConceptScore W4312210712C185592680 @default.
- W4312210712 hasConceptScore W4312210712C21951064 @default.
- W4312210712 hasConceptScore W4312210712C2776597398 @default.
- W4312210712 hasConceptScore W4312210712C42360764 @default.
- W4312210712 hasConceptScore W4312210712C43617362 @default.
- W4312210712 hasConceptScore W4312210712C530470458 @default.
- W4312210712 hasConceptScore W4312210712C71240020 @default.
- W4312210712 hasConceptScore W4312210712C71924100 @default.
- W4312210712 hasIssue "4" @default.
- W4312210712 hasLocation W43122107121 @default.
- W4312210712 hasLocation W43122107122 @default.
- W4312210712 hasOpenAccess W4312210712 @default.
- W4312210712 hasPrimaryLocation W43122107121 @default.
- W4312210712 hasRelatedWork W1985875828 @default.
- W4312210712 hasRelatedWork W2082654484 @default.
- W4312210712 hasRelatedWork W2088866967 @default.
- W4312210712 hasRelatedWork W2950046175 @default.
- W4312210712 hasRelatedWork W2952586170 @default.
- W4312210712 hasRelatedWork W2982079374 @default.
- W4312210712 hasRelatedWork W3004734743 @default.
- W4312210712 hasRelatedWork W3094019519 @default.
- W4312210712 hasRelatedWork W3200768928 @default.
- W4312210712 hasRelatedWork W4206458270 @default.
- W4312210712 hasVolume "13" @default.
- W4312210712 isParatext "false" @default.
- W4312210712 isRetracted "false" @default.
- W4312210712 workType "article" @default.